AI Article Synopsis
- In pulmonary heart disease, special therapy is not typically necessary unless in a decompensated state; the focus is on treating the underlying lung condition.
- The lecture emphasizes the importance of improving oxygen supply to patients with chronic cor pulmonale, specifically those experiencing ventilative-hypoxic issues.
- Lowering the elevated pulmonary artery pressure can be achieved through drug-induced bronchial dilation, which plays a key role in management.
Article Abstract
With the exception of the decompensated state there is no special therapy in the pulmonary heart disease. Therapy is mainly directed to the original lung disease. Regarding the frequency of the ventilative-hypoxic type of the cor pulmonale chronicum the main thing of this lecture is the improvement of oxygen supply and thereby the lowering of pulmonary artery pressure pathologically raised by drug-induced bronchial dilatation.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
pulmonary heart
8
heart disease
8
[latest state
4
state pharmacotherapy
4
pharmacotherapy pulmonary
4
disease author's
4
author's transl]
4
transl] exception
4
exception decompensated
4
decompensated state
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!